TRENAXA INJECTION contains Tranexamic Acid which belongs to the group of medicines called Antifibrinolytics. It is used in the management of bleeding in conditions such as heavy menstrual bleeding in women, gastrointestinal bleeding (bleeding in digestive tract, anywhere from the throat to rectum), bleeding due to thrombolytic therapy (medicine that is used to breakdown blood clots) and after having surgeries (such as ear, nose, throat, prostate gland, urinary tract, gynecological, abdominal or heart surgery) in adults and children above one year of age.
TRENAXA INJECTION is not recommended for use in patients with severe kidney impairment, blood clotting disorder or consumption coagulopathy (condition affecting the blood’s ability to clot and stop the bleeding) or history of seizures (fits). Your doctor may recommend you to take relevant tests to understand your existing condition.
Before receiving TRENAXA INJECTION, inform your doctor if you had or have blood in the urine, are at risk of having a blood clot, excessive clotting or bleeding throughout the body (disseminated intravascular coagulation).
TRENAXA INJECTION is not recommended for use in the first trimester of pregnancy and in breast-feeding women. It should be used with caution in pregnant women only if clearly advised by the doctor. TRENAXA INJECTION should be used with caution in elderly patients, especially in patients with the evidence of renal failure.
The most common side effects of receiving TRENAXA INJECTION are nausea or vomiting and diarrhea. Inform your doctor immediately if any of the side effect worsens.
No content available
